![ETH Zürich (Switzerland) and the United States National Cancer Institute (NCI) have just signed an extension of their MOU for Proteogenomics Cancer Research](https://oncodaily.com/pub/uploads/2023/07/1689020652464-1280x871.jpeg)
Photo taken from: Henry Rodriguez / LinkedIn
Jul 12, 2023, 03:28
ETH Zürich (Switzerland) and the United States National Cancer Institute (NCI) have just signed an extension of their MOU for Proteogenomics Cancer Research
Exciting news! ETH Zürich (Switzerland) and the United States National Cancer Institute (NCI) have just signed an extension of their MOU for Proteogenomics Cancer Research. Proud to have the Switzerland International Cancer Proteogenome Consortium (ICPC) team at ETH Zürich, contributing to our cancer moonshot global fight against cancer. Together, we’re pushing the boundaries of science to fight against this relentless disease. https://lnkd.in/ex4vhTFP
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023